Mangrove Partners Cortexyme, Inc. Transaction History
Mangrove Partners
- $890 Million
- Q2 2024
A detailed history of Mangrove Partners transactions in Cortexyme, Inc. stock. As of the latest transaction made, Mangrove Partners holds 11,000 shares of CRTX stock, worth $14,190. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,000Holding current value
$14,190% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CRTX
# of Institutions
48Shares Held
6.25MCall Options Held
101KPut Options Held
400-
Tang Capital Management LLC San Diego, CA1.5MShares$1.94 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.21MShares$1.57 Million0.0% of portfolio
-
Epiq Capital Group, LLC San Francisco, CA852KShares$1.1 Million0.41% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny484KShares$624,2330.0% of portfolio
-
Black Rock Inc. New York, NY355KShares$457,6760.0% of portfolio
About Cortexyme, Inc.
- Ticker CRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,150,800
- Market Cap $70.5M